Slow movement, tremor, and stiff muscles are all typical symptoms of Parkinson’s disease. They are due to loss of the ...

Parkinson's disease has been getting increased attention in the media, but misinformation abounds. Here, a Parkinson's expert ...

The chemical messenger dopamine is an essential catalyst that fuels activities and behaviors ranging from movement to ...

Vyalev is the first subcutaneous 24-hour continuous infusion of levodopa-based therapy for advanced Parkinson’s disease.

The FDA has just approved a new injectable treatment for adults with advanced Parkinson’s disease called Vyalev (also known as Produodopa).

The FDA on Thursday approved an injectable drug that eased Parkinson's disease symptoms and improved motor fluctuations in ...

A brain molecule has been found to reverse movement deficits in Parkinson’s, presenting a new potential therapeutic target. A ...

GOOD Morning Britain presenter John Stapleton has revealed that he’s been diagnosed with Parkinson’s disease. The broadcaster ...

An experimental first-in-class oral selective partial D1/D5 dopamine receptor agonist for Parkinson's significantly reduce ...

Caffeine Affects Brain Dopamine Function in Patients With Parkinson's Disease May 28, 2024 — Regular high caffeine consumption affects dopamine function in patients with Parkinson's disease ...

"We, 100% can tell everyone who comes in the room who is diagnosed with PD, if you exercise, your disease will go slower than ...

MeiraGTx is looking to march its Parkinson’s disease treatment forward into phase 3 after the gene therapy improved motor ...